NorthWest Biotherapeutics Inc (NWBO)

[theorysuit]

UK is a tiny market mostly because their reimbursement is crap (see car-t for example). It is doubtful that this UK market and NICE can bring any meaningful revenue in the foreseeable future. So that means more of the same daily dilution. The company needs to ask for more authorized shares soon. When this thing hits 2b plus authorized shares, $1 PPS equates to 2B valuation. And that isn't happening from the UK alone. Realistically speaking if you get a pump to $1, get out and don't ever look back.

Ask yourself, how long will it take to submit an FDA application? Do you think it will be quick, doubtful. And do you think this current team can actually market a complex autologous product with logistical challenges, also doubtful. I don't see anyone on their team with witb any biotech or pharma sales experience. You gotta be honest with yourself here and evaluate.